2022
DOI: 10.7759/cureus.25076
|View full text |Cite
|
Sign up to set email alerts
|

Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review

Abstract: Polycystic ovarian syndrome (PCOS) is considered the most common endocrine disorder affecting females in today's world. Although it has been primarily studied and discussed in terms of its reproductive symptoms such as infertility, amenorrhea or oligomenorrhea, acne, hirsutism, and mood disorders, there is yet another unexplored and under-diagnosed category in the PCOS spectrum of diseases: its cardio-metabolic consequences. PCOS patients are prone to these abnormalities from a very young age, increasing their… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 90 publications
0
18
0
Order By: Relevance
“…Metabolic syndrome (MetS) is a complex of cardiovascular disease and diabetes related risk factors, including hypertension, impaired fasting glucose, abdominal obesity and dyslipidemia (1)(2)(3). MetS is becoming a global problem that increasingly violates human health and quality of life, and the risk of its occurrence increases with age (4,5). In most developed countries, the prevalence of MetS in adults is about 20-30%, however in developing countries and regions, the prevalence of it is lower but nowadays is approaching or even surpassing that in developed countries (6).…”
Section: Introductionmentioning
confidence: 99%
“…Metabolic syndrome (MetS) is a complex of cardiovascular disease and diabetes related risk factors, including hypertension, impaired fasting glucose, abdominal obesity and dyslipidemia (1)(2)(3). MetS is becoming a global problem that increasingly violates human health and quality of life, and the risk of its occurrence increases with age (4,5). In most developed countries, the prevalence of MetS in adults is about 20-30%, however in developing countries and regions, the prevalence of it is lower but nowadays is approaching or even surpassing that in developed countries (6).…”
Section: Introductionmentioning
confidence: 99%
“…VD has protective effects on the cardiovascular system and on chronic and autoimmune diseases, regulates the expression of genes involved in glucose and lipid metabolism, and plays a key role in the reproductive system of women [ 6 , 45 , 83 ]. VD deficiency has been shown to be associated with many of the signs present in PCOS: ovulatory dysfunction, hyperandrogenism, insulin resistance, diabetes and dyslipidemia, adiposity indices, and systemic proinflammatory environments [ 25 , 64 , 84 ].…”
Section: Discussionmentioning
confidence: 99%
“…PCOS is also associated with hyperinsulinemia, impaired glucose tolerance, and sometimes even type 2 diabetes mellitus (T2DM) [ 4 ]. Factors such as insulin resistance (IR) dyslipidemia, endothelial connection, and systemic inflammation are other elements that add to this set of signs and symptoms and predispose patients to a higher risk of cardiovascular disease than women without PCOS [ 5 , 6 ]. Probably, the reduced insulin sensitivity leads to an inevitable compensatory hyperinsulinemia, and this contributes to the development of hyperandrogenism through a chronic stimulus directed toward the cells of the ovarian theca.…”
Section: Introductionmentioning
confidence: 99%
“…Early onset adiposity has been implicated in the pathogenesis of PCOS and can be predictive of a more severe phenotype. It is also linked to the development of low-grade inflammation, greater cardiometabolic dysfunction and future risk of atherosclerosis [ 12 - 15 ]. Our data shows that as an indicator of visceral fat function, VAI correlates well with severity of menstrual dysfunction and ovarian dysmorphology, and seems to be predictive of impaired glucose tolerance, thus indicating propensity for development of diabetes in the future.…”
Section: Discussionmentioning
confidence: 99%